Copyright Reports & Markets. All rights reserved.

Global Digital Biomarker Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered: Ranking by Digital Biomarker Revenue
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Digital Biomarker Market Size Growth Rate by Type: 2020 VS 2026
      • 1.4.2 Safety Biomarker
      • 1.4.3 Validation Biomarker
      • 1.4.4 Efficacy Biomarker
    • 1.5 Market by Application
      • 1.5.1 Global Digital Biomarker Market Share by Application: 2020 VS 2026
      • 1.5.2 Sleep and Movement
      • 1.5.3 Cardiovascular
      • 1.5.4 Mood and Behavior
      • 1.5.5 Pain Management
      • 1.5.6 Respiratory Conditions
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends by Regions

    • 2.1 Digital Biomarker Market Perspective (2015-2026)
    • 2.2 Digital Biomarker Growth Trends by Regions
      • 2.2.1 Digital Biomarker Market Size by Regions: 2015 VS 2020 VS 2026
      • 2.2.2 Digital Biomarker Historic Market Share by Regions (2015-2020)
      • 2.2.3 Digital Biomarker Forecasted Market Size by Regions (2021-2026)
    • 2.3 Industry Trends and Growth Strategy
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis
      • 2.3.5 Digital Biomarker Market Growth Strategy
      • 2.3.6 Primary Interviews with Key Digital Biomarker Players (Opinion Leaders)

    3 Competition Landscape by Key Players

    • 3.1 Global Top Digital Biomarker Players by Market Size
      • 3.1.1 Global Top Digital Biomarker Players by Revenue (2015-2020)
      • 3.1.2 Global Digital Biomarker Revenue Market Share by Players (2015-2020)
      • 3.1.3 Global Digital Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.2 Global Digital Biomarker Market Concentration Ratio
      • 3.2.1 Global Digital Biomarker Market Concentration Ratio (CR5 and HHI)
      • 3.2.2 Global Top 10 and Top 5 Companies by Digital Biomarker Revenue in 2019
    • 3.3 Digital Biomarker Key Players Head office and Area Served
    • 3.4 Key Players Digital Biomarker Product Solution and Service
    • 3.5 Date of Enter into Digital Biomarker Market
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type (2015-2026)

    • 4.1 Global Digital Biomarker Historic Market Size by Type (2015-2020)
    • 4.2 Global Digital Biomarker Forecasted Market Size by Type (2021-2026)

    5 Digital Biomarker Breakdown Data by Application (2015-2026)

    • 5.1 Global Digital Biomarker Market Size by Application (2015-2020)
    • 5.2 Global Digital Biomarker Forecasted Market Size by Application (2021-2026)

    6 North America

    • 6.1 North America Digital Biomarker Market Size (2015-2020)
    • 6.2 Digital Biomarker Key Players in North America (2019-2020)
    • 6.3 North America Digital Biomarker Market Size by Type (2015-2020)
    • 6.4 North America Digital Biomarker Market Size by Application (2015-2020)

    7 Europe

    • 7.1 Europe Digital Biomarker Market Size (2015-2020)
    • 7.2 Digital Biomarker Key Players in Europe (2019-2020)
    • 7.3 Europe Digital Biomarker Market Size by Type (2015-2020)
    • 7.4 Europe Digital Biomarker Market Size by Application (2015-2020)

    8 China

    • 8.1 China Digital Biomarker Market Size (2015-2020)
    • 8.2 Digital Biomarker Key Players in China (2019-2020)
    • 8.3 China Digital Biomarker Market Size by Type (2015-2020)
    • 8.4 China Digital Biomarker Market Size by Application (2015-2020)

    9 Japan

    • 9.1 Japan Digital Biomarker Market Size (2015-2020)
    • 9.2 Digital Biomarker Key Players in Japan (2019-2020)
    • 9.3 Japan Digital Biomarker Market Size by Type (2015-2020)
    • 9.4 Japan Digital Biomarker Market Size by Application (2015-2020)

    10 Southeast Asia

    • 10.1 Southeast Asia Digital Biomarker Market Size (2015-2020)
    • 10.2 Digital Biomarker Key Players in Southeast Asia (2019-2020)
    • 10.3 Southeast Asia Digital Biomarker Market Size by Type (2015-2020)
    • 10.4 Southeast Asia Digital Biomarker Market Size by Application (2015-2020)

    11 India

    • 11.1 India Digital Biomarker Market Size (2015-2020)
    • 11.2 Digital Biomarker Key Players in India (2019-2020)
    • 11.3 India Digital Biomarker Market Size by Type (2015-2020)
    • 11.4 India Digital Biomarker Market Size by Application (2015-2020)

    12 Central & South America

    • 12.1 Central & South America Digital Biomarker Market Size (2015-2020)
    • 12.2 Digital Biomarker Key Players in Central & South America (2019-2020)
    • 12.3 Central & South America Digital Biomarker Market Size by Type (2015-2020)
    • 12.4 Central & South America Digital Biomarker Market Size by Application (2015-2020)

    13 Key Players Profiles

    • 13.1 ActiGraph
      • 13.1.1 ActiGraph Company Details
      • 13.1.2 ActiGraph Business Overview and Its Total Revenue
      • 13.1.3 ActiGraph Digital Biomarker Introduction
      • 13.1.4 ActiGraph Revenue in Digital Biomarker Business (2015-2020))
      • 13.1.5 ActiGraph Recent Development
    • 13.2 Akili Interactive Labs
      • 13.2.1 Akili Interactive Labs Company Details
      • 13.2.2 Akili Interactive Labs Business Overview and Its Total Revenue
      • 13.2.3 Akili Interactive Labs Digital Biomarker Introduction
      • 13.2.4 Akili Interactive Labs Revenue in Digital Biomarker Business (2015-2020)
      • 13.2.5 Akili Interactive Labs Recent Development
    • 13.3 AliveCor
      • 13.3.1 AliveCor Company Details
      • 13.3.2 AliveCor Business Overview and Its Total Revenue
      • 13.3.3 AliveCor Digital Biomarker Introduction
      • 13.3.4 AliveCor Revenue in Digital Biomarker Business (2015-2020)
      • 13.3.5 AliveCor Recent Development
    • 13.4 Fitbit
      • 13.4.1 Fitbit Company Details
      • 13.4.2 Fitbit Business Overview and Its Total Revenue
      • 13.4.3 Fitbit Digital Biomarker Introduction
      • 13.4.4 Fitbit Revenue in Digital Biomarker Business (2015-2020)
      • 13.4.5 Fitbit Recent Development
    • 13.5 HumanAPI
      • 13.5.1 HumanAPI Company Details
      • 13.5.2 HumanAPI Business Overview and Its Total Revenue
      • 13.5.3 HumanAPI Digital Biomarker Introduction
      • 13.5.4 HumanAPI Revenue in Digital Biomarker Business (2015-2020)
      • 13.5.5 HumanAPI Recent Development
    • 13.6 Novartis
      • 13.6.1 Novartis Company Details
      • 13.6.2 Novartis Business Overview and Its Total Revenue
      • 13.6.3 Novartis Digital Biomarker Introduction
      • 13.6.4 Novartis Revenue in Digital Biomarker Business (2015-2020)
      • 13.6.5 Novartis Recent Development
    • 13.7 Pfizer
      • 13.7.1 Pfizer Company Details
      • 13.7.2 Pfizer Business Overview and Its Total Revenue
      • 13.7.3 Pfizer Digital Biomarker Introduction
      • 13.7.4 Pfizer Revenue in Digital Biomarker Business (2015-2020)
      • 13.7.5 Pfizer Recent Development
    • 13.8 Roche
      • 13.8.1 Roche Company Details
      • 13.8.2 Roche Business Overview and Its Total Revenue
      • 13.8.3 Roche Digital Biomarker Introduction
      • 13.8.4 Roche Revenue in Digital Biomarker Business (2015-2020)
      • 13.8.5 Roche Recent Development
    • 13.9 Sanofi
      • 13.9.1 Sanofi Company Details
      • 13.9.2 Sanofi Business Overview and Its Total Revenue
      • 13.9.3 Sanofi Digital Biomarker Introduction
      • 13.9.4 Sanofi Revenue in Digital Biomarker Business (2015-2020)
      • 13.9.5 Sanofi Recent Development
    • 13.10 Takeda Pharmaceuticals
      • 13.10.1 Takeda Pharmaceuticals Company Details
      • 13.10.2 Takeda Pharmaceuticals Business Overview and Its Total Revenue
      • 13.10.3 Takeda Pharmaceuticals Digital Biomarker Introduction
      • 13.10.4 Takeda Pharmaceuticals Revenue in Digital Biomarker Business (2015-2020)
      • 13.10.5 Takeda Pharmaceuticals Recent Development

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Disclaimer

      This report focuses on the global Digital Biomarker status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Digital Biomarker development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      ActiGraph
      Akili Interactive Labs
      AliveCor
      Fitbit
      HumanAPI
      Novartis
      Pfizer
      Roche
      Sanofi
      Takeda Pharmaceuticals

      Market segment by Type, the product can be split into
      Safety Biomarker
      Validation Biomarker
      Efficacy Biomarker
      Market segment by Application, split into
      Sleep and Movement
      Cardiovascular
      Mood and Behavior
      Pain Management
      Respiratory Conditions

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Digital Biomarker status, future forecast, growth opportunity, key market and key players.
      To present the Digital Biomarker development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by type, market and key regions.

      In this study, the years considered to estimate the market size of Digital Biomarker are as follows:
      History Year: 2015-2019
      Base Year: 2019
      Estimated Year: 2020
      Forecast Year 2020 to 2026
      For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now